Partners' Directory

  Home   Search   Join the Partnership   Login

Contact General Specializations in Countries Contribution to the Global Plan Declaration

View this partner's profile

Organization Contact Information

Name: National Center for Tuberculosis Control and Prevention of China CDC
Street 1: No. 155 Changbai Road /Changping District/Beijing/P.R.China
Street 2:
City: Beijing
Province: Beijing
Post Code: 102206
Country: China
Phone: 86158900516
Email: chenmt@chinatb.org
Web Site: http://www.chinatb.org

Focal Point Contact Information

Salutation: Dr
First Name: Mingting
Last Name: Chen
Title: vice director
Email: chenmt@chinatb.org
Phone: 86158900516

Alternate Focal Point Contact Information

Salutation: Dr
First Name: Qing
Last Name: Lv
Title: director/researcher
Email: lvqing@chinatb.org
Phone: 86158900514

General Information

Board Constituency: Countries
Organization Type - Primary: Governmental Organization
Organization Type - Secondary: None
Is your organization legally registered in your country: Yes
Organization Reach: National
Organization Description:
National Center for Tuberculosis Control and Prevention is a speacial institute for tuberculosis control in China. It is responsible for the implementation of national TB control program(NTP) in China. Specifically, it is responsible for program/project planning, development of technical guidelines, training, surveillance, research, program monitoring and evaluation,laboratory reference and international collaboration. It's vision is to be the domestically and internationally recognized authority in TB and other related fields.

From 2002, we have been carrying out several projects including WB/DFID China TB control project, Japan-assisted China TB control project, DFB China TB control project, CIDA-WHO China TB control project ,GFATM projects and Gates Foundation TB project. We are integrating all individual projects into NTP as a whole with most reasonable and effective allocation of various resources and proper management.
In addition,We have begun our MDR-TB control and prevention program by Globe Fund'surpport and do research on MDR-TB diagnosis, treatment and management by Gates Foundation surport. But we still need more funding to fight the MDR-TB.
 
Total number of staff in your organization: 51 - 99
Number of full-time staff who are directly involved with TB: 51 - 99
Number of part-time staff who are directly involved with TB: 0
Number of volunteers who are directly involved with TB: 0
 
What is your organization's annual budget (USD) dedicated to TB? $500,001-$1 MIL
How did you hear about the Stop TB Partnership: Attendance at a TB related event
If you were informed or referred by another partner of the Stop TB Partnership please tell us who:
Why do you wish join the Stop TB Partnership: Information on developments within the TB world
 
Are you a member of a Stop TB national partnership: No
Are you in contact with your national TB programme: Yes
Please tell us how your organization is contributing to your country's national TB control plan:
NCTB is resposible for Chinese TB control plan
 

Geographical Reach

Which country is your headquarters located in: China
Which WHO region is the main focus of your work: Western Pacific
Which countries do you do operate in:
(This includes countries you are conducting activities in)
China

Specializations

Advocacy
Delivery of health services and care
Funding, including innovative and optimized approach to funding TB Care
Provision of drugs, diagnostics and commodities
Research and Development
Technical Assistance

Specializations in Countries

Technical Assistance China

Contribution

Please tell us how your organization will contribute to the Global Plan to Stop TB by briefly describing its involvement in any of the areas of work listed below:

TB Care Delivery:
Change the mode to TB srvice, let hospoital play an important role in TB control and prevntion.

Drug-Resistant TB:
MDR-TB diagnosis,treatment and management

TB-HIV:
early TB diagnosis to HIV and AIDS patient, early HIV detection to TB patient

Laboratory Strengthening:
laboratory reference, resaerch etc.

New Diagnostics:
rearch some new diagnosis regent.

New TB Drugs:
Begin to use some new TB drugs to treatment MDR-TB patient.

New TB Vaccines:
Try the second clinical test to a new TB Vaccine.

Fundamental Research:
have do some research in Diagnosis, vaccine and TB drugs.

Research:
have been done a lot of operational research about TB control and prevention.

Declaration

Declaration of interests:
No conflicts of interest were delacred.

Application date:  
Last updated: February 20, 2013